Coral Laboratories Q4 Results
- BSE: 524506
- NSE: -
- ISIN: INE683E01017
- Sector: Biotechnology & Drugs
BSE
423.95
-10.00 (-2.28%)
-10.00 (-2.28%)Volume5.00 K
Updated: Mon 16 Mar, 2026 | 09:17:02
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Coral Laboratories Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 26.73 | 20.36 | 55.60% | 23.23 | 15.03% |
| Depreciation/ Amortization | 0.51 | 0.69 | 0.92% | 0.50 | 0.64% |
| Operating Income | 1.41 | 1.20 | -75.75% | 5.65 | -75.07% |
| Net Income | 2.83 | 2.78 | -53.99% | 5.79 | -51.15% |
| Other Operating Expenses Total | 7.05 | 6.59 | 84.27% | 6.94 | 1.48% |
| Net Income Before Taxes | 3.85 | 3.70 | -53.68% | 7.74 | -50.27% |
| Total Revenue | 28.13 | 21.56 | 22.40% | 28.89 | -2.60% |
| Selling/ General/ Admin Expenses Total | 3.83 | 4.40 | 13.24% | 3.34 | 14.57% |
| Diluted Normalized EPS | 9.49 | 7.77 | -44.80% | 16.38 | -42.05% |